WHO ICTRP trial
Pharmacokinetic and pharmacodynamic target attainment of amoxicillin(-clavulanic…
NL-OMON49528 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON49528 |
|---|---|
| Public title | Pharmacokinetic and pharmacodynamic target attainment of amoxicillin(-clavulanic acid) in pleural empyema fluid and complicated parapneumonic effusion |
| Scientific title | Pharmacokinetic and pharmacodynamic target attainment of amoxicillin(-clavulanic acid) in pleural empyema fluid and complicated parapneumonic effusion - Empyema-study |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | pleural effusion Pus in the area between the lungs;10004018;pleural effusion;Pus in the area between the lungs |
| Interventions | ;Antibiotics;Complicated parapneumonic effusion;PK/PD target attainment;Pleural empyema |
| Registration date | May 7, 2020 |
| Target size | 20 |
| Secondary IDs | NL72499.018.20 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: